Guidelines for the management of rheumatoid arthritis: 2002 Update.

Rheumatoid arthritis (RA) is a progressive polyarthritis that is responsible for over nine million office visits annually. It is likely that most nurse practitioners will care for one or more patients with RA because approximately 1% of the adult population is affected by this disabling disorder. The guideline reviewed in this month’s column describes the recommended care of patients who have been previously diagnosed with RA. Author Grace Newsome, EdD, APRN-BC, FNP, is an Associate Professor of Nursing, North Georgia College & State University, Dahlonega, GA.

[1]  H. Holman,et al.  Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.

[2]  J. Jacobs,et al.  Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial , 2000, Annals of the rheumatic diseases.

[3]  R. Dahl,et al.  A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. , 2000, Rheumatology.

[4]  A. Cats,et al.  Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. , 1986, Annals of the rheumatic diseases.

[5]  D. M. Chaput de Saintonge,et al.  Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo. , 1981, Annals of the rheumatic diseases.

[6]  D. Scott,et al.  Prognostic factors in early rheumatoid arthritis. , 2000, Rheumatology.

[7]  J. Kremer Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: followup after a mean of 13.3 years. , 1997, Arthritis and rheumatism.

[8]  M. Hochberg,et al.  Adult and juvenile rheumatoid arthritis: current epidemiologic concepts. , 1981, Epidemiologic reviews.

[9]  J J Anderson,et al.  The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .

[10]  C. Ranawat Surgical management of the rheumatoid hip. , 1998, Rheumatic diseases clinics of North America.

[11]  Richard W. Martin,et al.  A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.

[12]  M. Urowitz,et al.  Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1992, Arthritis and rheumatism.

[13]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.

[14]  B. Dijkmans,et al.  A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[15]  J. Lifson,et al.  Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. , 1985, Annals of internal medicine.

[16]  Minocycline in active rheumatoid arthritis , 1994 .

[17]  M. Ahern,et al.  A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. , 1991, Australian and New Zealand journal of medicine.

[18]  M. Corbett,et al.  Radiographic changes in early rheumatoid disease. , 1977, Annals of the rheumatic diseases.

[19]  N. Cooper Economic burden of rheumatoid arthritis: a systematic review. , 2000, Rheumatology.

[20]  T. Möttönen,et al.  Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. , 1988, Annals of the rheumatic diseases.

[21]  M. A. van 't Hof,et al.  Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[22]  L. V. D. van de Putte,et al.  Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. , 1997, British journal of rheumatology.

[23]  F. Breedveld,et al.  Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. , 1998, Arthritis and rheumatism.

[24]  M. Guttadauria,et al.  Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1985, Arthritis and rheumatism.

[25]  B. Kramer,et al.  Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. , 1997, Research in nursing & health.

[26]  J. Kremer,et al.  A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. , 1999, The New England journal of medicine.

[27]  G. Alarcón,et al.  Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. , 1989, Arthritis and rheumatism.

[28]  P. Tugwell,et al.  Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled t , 2000, Arthritis and rheumatism.

[29]  M. Weinblatt,et al.  Efficacy of low-dose methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.

[30]  D. Felson,et al.  The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. , 1999, Arthritis and rheumatism.

[31]  H. Paulus,et al.  Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. , 1990, Arthritis and rheumatism.

[32]  J. Smolen,et al.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial , 1999, The Lancet.

[33]  J. Klippel,et al.  Second-line drug therapy for rheumatoid arthritis. , 1994, The New England journal of medicine.

[34]  M. A. van 't Hof,et al.  Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis , 2001, Annals of the rheumatic diseases.

[35]  D. Furst,et al.  Etanercept Therapy in Rheumatoid Arthritis , 1999, Annals of Internal Medicine.

[36]  M. Guttadauria,et al.  Methotrexate in Rheumatoid Arthritis: Impact on Quality of Life Assessed by Traditional Standard-Item and Individualized Patient Preference Health Status Questionnaires , 1990 .

[37]  M. Urowitz,et al.  Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis , 1992 .

[38]  P. Brooks,et al.  Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. , 1992, Annals of the rheumatic diseases.

[39]  M. Miller,et al.  Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone. , 1995, Arthritis and rheumatism.

[40]  J. Moreland,et al.  Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. , 1971, Arthritis and rheumatism.

[41]  J. Esdaile,et al.  Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. , 1993, Arthritis and rheumatism.

[42]  D. Stablein,et al.  Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment. , 1995, Arthritis and rheumatism.

[43]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[44]  D. Hungerford,et al.  Eliminating patellofemoral complications in total knee arthroplasty: clinical and radiographic results of 121 consecutive cases using the Duracon system. , 1999, The Journal of arthroplasty.

[45]  J. Kremer,et al.  Combination Therapy with Multiple Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Preventive Strategy , 1999, Annals of Internal Medicine.

[46]  V. Strand,et al.  Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. , 1999, Archives of internal medicine.

[47]  J. O'dell,et al.  Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. , 1999, Arthritis and rheumatism.

[48]  S. Pillemer,et al.  Minocycline in Rheumatoid Arthritis: A 48-Week, Double-Blind, Placebo-Controlled Trial , 1995, Annals of Internal Medicine.

[49]  M. Wolfe,et al.  Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. , 1999, The New England journal of medicine.

[50]  T. Pullar,et al.  Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. , 1983, British medical journal.

[51]  J. O'dell,et al.  Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. , 1997, Arthritis and rheumatism.

[52]  G. Alarcón,et al.  Supplementation with Folic Acid during Methotrexate Therapy for Rheumatoid Arthritis: A Double-Blind, Placebo-Controlled Trial , 1994, Annals of Internal Medicine.

[53]  J. Kremer,et al.  Methotrexate for Rheumatoid Arthritis , 1994 .

[54]  P. Hannonen,et al.  Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study. , 1993, Arthritis and rheumatism.

[55]  D. Heijde,et al.  EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS , 1989, The Lancet.

[56]  V. Strand,et al.  Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis , 1995 .

[57]  M. Hochberg,et al.  Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996 .

[58]  R N Maini,et al.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.

[59]  C. Hawkey,et al.  Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. , 1996, The New England journal of medicine.

[60]  J. Kirwan,et al.  The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. , 1995, The New England journal of medicine.

[61]  C. Kwoh,et al.  Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. , 1996, Arthritis and rheumatism.

[62]  P. Tugwell,et al.  Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. , 1999, Arthritis and rheumatism.

[63]  E. Yelin,et al.  An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. , 1999, Arthritis and rheumatism.

[64]  J. Kremer,et al.  Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[65]  A. Stewart,et al.  Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. , 1999, Medical care.

[66]  J. Hazes,et al.  Dynamic exercise therapy in rheumatoid arthritis: a systematic review. , 1998, British journal of rheumatology.

[67]  A. van der Heide,et al.  The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs , 1996, Annals of Internal Medicine.

[68]  J. O'dell,et al.  Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. , 1996, The New England journal of medicine.

[69]  S. van der Linden,et al.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.

[70]  M. Guttadauria,et al.  Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1983, Arthritis and rheumatism.

[71]  Z Domljan,et al.  Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. , 1998, Arthritis and rheumatism.

[72]  T. Revenson,et al.  Assessing the impact of self-efficacy beliefs on adaptation to rheumatoid arthritis. , 1991, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[73]  V. Strand,et al.  Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. , 2000, Arthritis and rheumatism.

[74]  J. Kremer,et al.  Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. , 1992, Arthritis and rheumatism.

[75]  P. Hannonen,et al.  Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. , 1998, British journal of rheumatology.

[76]  A. Barkun,et al.  Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs , 1998 .

[77]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[78]  G. Alarcón,et al.  Lack of association between HLA-DR2 and clinical response to methotrexate in patients with rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[79]  M. Dougados,et al.  Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components , 1999, Annals of the rheumatic diseases.

[80]  P. Hannonen,et al.  Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial , 1999, The Lancet.

[81]  F. Epstein,et al.  Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.

[82]  A. Whelton Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. , 1999, The American journal of medicine.

[83]  M. Picot,et al.  Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study. , 1997, British journal of rheumatology.

[84]  T. Revenson The role of social support with rheumatic disease. , 1993, Bailliere's clinical rheumatology.

[85]  F. Wolfe,et al.  The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. , 1998, Arthritis and rheumatism.

[86]  H. Genant,et al.  A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. , 2000, Arthritis and rheumatism.

[87]  J. Block,et al.  The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial. , 1999, Arthritis and rheumatism.

[88]  M. Weisman,et al.  A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[89]  P. Tugwell,et al.  Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry. , 1996, Arthritis and rheumatism.

[90]  P. Dawes,et al.  Should disease-modifying agents be used in mild rheumatoid arthritis? , 1991, British journal of rheumatology.

[91]  D. Felson,et al.  The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. , 1990, Arthritis and rheumatism.

[92]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[93]  P. Tugwell,et al.  Hydroxychloroquine Compared with Placebo in Rheumatoid Arthritis , 1993, Annals of Internal Medicine.

[94]  S D Cook,et al.  Long-term follow-up of pyrolytic carbon metacarpophalangeal implants. , 1999, The Journal of bone and joint surgery. American volume.

[95]  D. Lubeck,et al.  Outcomes of self-help education for patients with arthritis. , 1985, Arthritis and rheumatism.

[96]  P. Lipsky,et al.  Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial , 1999, The Lancet.

[97]  C. Hawkey,et al.  A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. , 1998, The New England journal of medicine.

[98]  F. Salaffi,et al.  Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis. , 1996, Scandinavian journal of rheumatology.

[99]  K. Kuntz,et al.  A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[100]  R. M. Mason,et al.  Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. , 1975, Annals of the rheumatic diseases.

[101]  M. Cohen,et al.  Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. , 1995, The American journal of medicine.

[102]  D. Mitchell,et al.  Preliminary criteria for clinical remission in rheumatoid arthritis. , 1981, Arthritis and rheumatism.

[103]  F. Wolfe,et al.  Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. , 1994, Arthritis and rheumatism.

[104]  R. Altman,et al.  Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. , 1992, The American journal of medicine.

[105]  G. Alarcón,et al.  The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[106]  H T Hatoum,et al.  Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. , 1996, Archives of internal medicine.

[107]  H K Genant,et al.  How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? , 1985, Arthritis and rheumatism.

[108]  J. Kirwan,et al.  Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. , 1998, British journal of rheumatology.

[109]  P. Tugwell,et al.  Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. , 1995, The New England journal of medicine.

[110]  J. Callaghan,et al.  Total Hip Arthroplasty with Cement in Patients Who Have Rheumatoid Arthritis. A Minimum Ten-Year Follow-up Study* , 1998, The Journal of bone and joint surgery. American volume.

[111]  M. Urowitz,et al.  Azathioprine in rheumatoid arthritis. A double-blind, cross over study. , 1973, Arthritis & Rheumatism.

[112]  P. Gertman,et al.  Measuring health status in arthritis. The arthritis impact measurement scales. , 1980, Arthritis and rheumatism.

[113]  G. Iverson,et al.  Cognitive-behavioral approaches to pain management in rheumatoid arthritis. , 1993, Arthritis care and research : the official journal of the Arthritis Health Professions Association.